Skip to main content
. 2021 Jun 12;906:174248. doi: 10.1016/j.ejphar.2021.174248

Fig. 4.

Fig. 4

Quantitative analysis for MERS-CoV mortality and IFN/RBV administration vs. no IFN/RBV.